Physician

Carleigh B Golden, M.D.

According to 2025 Medicare claims, Carleigh Golden, M.D. (NPI: 1174905996) practices internal medicine in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Pottawattamie, IA. This provider's primary affiliated billing organization is PHYSICIANS CLINIC INC (NPI: 1821049156; TIN: 470687317) and primary practice location at 51503-4643. Golden is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and Nebraska Health Network, LLC (ACO ID: A3273), participating under the MSSP model.

Golden's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 105 traditional Medicare patients, billed 1,091 HCPCS/CPT codes, and received $42,053 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 1,053 prescription claims across 192 beneficiaries totaling $105,747 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 13 claims. Open Payments data shows 95 records totaling $1,950. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $12,989 to $42,053. Similarly, Part D prescription costs have risen steadily, from $4,006 to $105,747. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	112	284	$12,989
2019	216	953	$38,304
2020	97	594	$22,076
2021	121	1,113	$43,211
2022	115	702	$34,964
2023	N/R	N/R	N/R
2024	105	1,091	$42,053

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	30	72	$4,006
2017	25	99	$3,292
2018	89	217	$11,264
2019	225	1,095	$76,477
2020	143	1,068	$92,947
2021	170	1,639	$181,711
2022	221	2,383	$245,971
2023	84	278	$29,208
2024	192	1,053	$105,747

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	13	13	$2,151
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	22	$726
2023	N/R	35	$1,362
2024	N/R	13	$505

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	20	20	$120
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	43	43	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	72	125	$86
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	64	103	$12
36415	Insertion of needle into vein for collection of blood sample	67	113	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	20	560	$21,086
Ozempic	Semaglutide	12	364	$11,438
Repatha Syringe	Evolocumab	12	336	$6,603
Ezetimibe	Ezetimibe	12	990	$874
Levothyroxine Sodium	Levothyroxine Sodium	48	3,502	$501

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	13	$505

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	95	$1,950	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carleigh B. Golden, M.D.?

Tedicare shows public-source Medicare data for Carleigh B. Golden, M.D. (NPI 1174905996), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carleigh B. Golden, M.D. have ACO affiliation data?

Carleigh B. Golden, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and Nebraska Health Network, LLC (MSSP, ACO ID A3273).

What billing organization is linked to Carleigh B. Golden, M.D.?

Carleigh B. Golden, M.D. is linked to PHYSICIANS CLINIC INC (billing NPI 1821049156) in the available physician profile data.

Does Carleigh B. Golden, M.D. have Open Payments data?

Carleigh B. Golden, M.D. has 95 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.